Jade Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Jade Biosciences (JBIO).

Price Target Range — 7 Quarters

Analyst Consensus — 6 Analysts

6Buy

Consensus RatingBuy# Analysts6Avg. Consensus PT$47Upside to Avg. PT+225.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 1, 2026	Wedbush	Laura Chico	Maintained	Outperform	$47
Oct 1, 2026	HC Wainwright & Co.	Arthur He	Maintained	Buy	$55
Aug 11, 2026	Wedbush	Laura Chico	PT Raise	Outperform	$45→$47
Aug 10, 2026	BTIG	Julian Harrison	PT Raise	Buy	$74→$77
Jun 15, 2026	UBS	Michael Yee	Initiate	Buy	$45
Jun 2, 2026	Wedbush	Laura Chico	PT Raise	Outperform	$34→$45
Jun 1, 2026	BTIG	Julian Harrison	PT Raise	Buy	$39→$74
Jun 1, 2026	HC Wainwright & Co.	Arthur He	PT Raise	Buy	$45→$55
May 27, 2026	BTIG	Julian Harrison	Maintained	Buy	$39
May 11, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$23→$32
May 11, 2026	Wedbush	Laura Chico	PT Raise	Outperform	$24→$34
Apr 27, 2026	HC Wainwright & Co.	Arthur He	PT Raise	Buy	$35→$45
Mar 25, 2026	HC Wainwright & Co.	Arthur He	PT Raise	Buy	$25→$35
Mar 16, 2026	BTIG	Julian Harrison	PT Raise	Buy	$28→$39
Mar 11, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$17→$23
Mar 9, 2026	Wedbush	Laura Chico	Maintained	Outperform	$24
Jan 7, 2026	HC Wainwright & Co.	Arthur He	Initiate	Buy	$25
Nov 25, 2025	Clear Street	Kaveri Pohlman	Initiate	Buy	$25
Nov 18, 2025	Guggenheim	Vamil Divan	PT Raise	Buy	$14→$17
Oct 9, 2025	BTIG	Julian Harrison	Initiate	Buy	$28

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wedbush Reiterates Outperform on Jade Biosciences, Maintains $47 Price Target

Wedbush analyst Laura Chico reiterates Jade Biosciences (NASDAQ:JBIO) with a Outperform and maintains $47 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Jade Biosciences, Maintains $55 Price Target

HC Wainwright & Co. analyst Arthur He reiterates Jade Biosciences (NASDAQ:JBIO) with a Buy and maintains $55 price target.

Benzinga Newsdesk

PRO
Wedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $47

Wedbush analyst Laura Chico maintains Jade Biosciences (NASDAQ:JBIO) with a Outperform and raises the price target from $45 to $47.

Benzinga Newsdesk

PRO
UBS Initiates Coverage On Jade Biosciences with Buy Rating, Announces Price Target of $45

UBS analyst Michael Yee initiates coverage on Jade Biosciences (NASDAQ:JBIO) with a Buy rating and announces Price Target of $45.

Benzinga Newsdesk

PRO
Wedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $45

Wedbush analyst Laura Chico maintains Jade Biosciences (NASDAQ:JBIO) with a Outperform and raises the price target from $34 to $45.

Benzinga Newsdesk

Why Is Jade Biosciences Stock Trading Lower On Monday?

Jade Biosciences reports Phase 1 JADE101 data showing sustained IgA reductions in IgAN, while analyst addresses ADA concerns and timeline expectations.

Vandana Singh

Jade Biosciences Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Jade Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Wedbush Reiterates Outperform on Jade Biosciences, Maintains $47 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Jade Biosciences, Maintains $55 Price Target

PRO
Wedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $47

PRO
UBS Initiates Coverage On Jade Biosciences with Buy Rating, Announces Price Target of $45

PRO
Wedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $45

Why Is Jade Biosciences Stock Trading Lower On Monday?

People Also Watch

People Also Watch

Jade Biosciences Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Jade Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROWedbush Reiterates Outperform on Jade Biosciences, Maintains $47 Price Target

PROHC Wainwright & Co. Reiterates Buy on Jade Biosciences, Maintains $55 Price Target

PROWedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $47

PROUBS Initiates Coverage On Jade Biosciences with Buy Rating, Announces Price Target of $45

PROWedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $45

Why Is Jade Biosciences Stock Trading Lower On Monday?

People Also Watch

People Also Watch

PRO
Wedbush Reiterates Outperform on Jade Biosciences, Maintains $47 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Jade Biosciences, Maintains $55 Price Target

PRO
Wedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $47

PRO
UBS Initiates Coverage On Jade Biosciences with Buy Rating, Announces Price Target of $45

PRO
Wedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $45